Nanox to Report Second Quarter and Financial Results on August 20, 2024
Nanox to Report Second Quarter and Financial Results on August 20, 2024
PETACH TIKVA, Israel, Aug. 06, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company," Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended June 30, 2024, before market open on Tuesday, August 20, 2024. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET.
以色列彼塔克提克瓦，2024年8月6日 /美通社/ -- 创新医疗影像技术公司纳诺克斯影像有限公司(Nanox或"该公司"，纳斯达克股票代码：NNOX)今天宣布，将于2024年8月20日星期二美国东部时间上午8:30公布截至2024年6月30日季度财报。首席执行官暨代理主席埃雷兹·梅尔泽(Erez Meltzer)和首席财务官兰·丹尼尔(Ran Daniel)将主持电话会议，审查这些结果并提供业务更新。
Interested parties may register for the conference call using the following link: Nanox Q2 Earnings Call Registration. You may access the live webcast of the conference call by using the following link: Nanox Q2 Earnings Webcast. The link will also be posted in the Investor Relations section of the Nanox website at Events and Presentations. An archived replay of the webcast will also be available on the website shortly after the completion of the call.
有意参加电话会议的人士可以使用以下链接进行注册：Nanox Q2 Ernings Call Registration。您可以使用以下链接访问电话会议的直播网络广播：Nanox Q2 Ernings Webcast。该链接也将发布在纳诺克斯网站的投资者关系--活动和演示文稿栏目中。网路广播的存档回放也将在电话会议结束后不久在网站上提供。
About Nanox
关于Nanox
Nanox (NASDAQ: NNOX) is focused on applying its proprietary medical imaging technology and solutions to make diagnostic medicine more accessible and affordable across the globe. Nanox's vision is to increase access, reduce costs and enhance the efficiency of routine medical imaging technology and processes, in order to improve early detection and treatment, which Nanox believes is key to helping people achieve better health outcomes, and, ultimately, to save lives. The Nanox ecosystem includes Nanox.ARC— a multi-source Digital Tomosynthesis system that is cost-effective and user-friendly; an AI-based suite of algorithms that augment the readings of routine CT imaging to highlight early signs often related to chronic disease (Nanox.AI); a cloud-based infrastructure (Nanox.CLOUD); and a proprietary decentralized marketplace, through Nanox's subsidiary, USARAD Holdings Inc., that provides remote access to radiology and cardiology experts; and a comprehensive teleradiology services platform (Nanox.MARKETPLACE). Together, Nanox's products and services create a worldwide, innovative, and comprehensive solution that connects medical imaging solutions, from scan to diagnosis. For more information, please visit .
纳诺克斯影像有限公司(NASDAQ: NNOX)专注于应用专有的医疗影像技术和解决方案，使全球的诊断医学更具可访问性和可承担性。纳诺克斯的愿景是提高医学影像技术和流程的效率，以实现更早期的检测和治疗，这被认为是有助于人们获得更好的健康结果，并最终挽救生命的关键。纳诺克斯的生态系统包括Nanox.ARC -- 一种多源数字断层摄影系统，具有成本效益和用户友好性；一套基于人工智能的算法( Nanox.AI)，可增强常规CT影像的读数，以突出与慢性疾病常有关联的早期迹象；云计算基础设施(Nanox.CLOUD);通过纳诺克斯子公司USARAD Holdings Inc.提供远程影像学和心脏病学专家的专业分散市场；以及一个综合的遥诊服务平台(Nanox.MARKETPLACE)。纳诺克斯的产品和服务共同构成了一个全球创新和综合的解决方案，连接了医学影像解决方案，从扫描到诊断。欲了解更多信息，请访问。
ContactsMedia Contact:Ben ShannonICR WestwickeNanoxPR@icrinc.comInvestor Contact:Mike CavanaughICR Westwickemike.cavanaugh@westwicke.com
媒体联系人：Ben Shannon，ICR Westwicke，NanoxPR@icrinc.com；投资者联系人：Mike Cavanaugh，ICR Westwicke，mike.cavanaugh@westwicke.com。